Literature DB >> 27215853

Telomere-associated aging disorders.

Patricia L Opresko1, Jerry W Shay2.   

Abstract

Telomeres are dynamic nucleoprotein-DNA structures that cap and protect linear chromosome ends. Several monogenic inherited diseases that display features of human premature aging correlate with shortened telomeres, and are referred to collectively as telomeropathies. These disorders have overlapping symptoms and a common underlying mechanism of telomere dysfunction, but also exhibit variable symptoms and age of onset, suggesting they fall along a spectrum of disorders. Primary telomeropathies are caused by defects in the telomere maintenance machinery, whereas secondary telomeropathies have some overlapping symptoms with primary telomeropathies, but are generally caused by mutations in DNA repair proteins that contribute to telomere preservation. Here we review both the primary and secondary telomeropathies, discuss potential mechanisms for tissue specificity and age of onset, and highlight outstanding questions in the field and future directions toward elucidating disease etiology and developing therapeutic strategies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Premature aging; RecQ helicases; Telomerase; Telomere

Mesh:

Substances:

Year:  2016        PMID: 27215853     DOI: 10.1016/j.arr.2016.05.009

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  59 in total

Review 1.  Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases.

Authors:  Michael Patrick; Nan-Ping Weng
Journal:  Cell Immunol       Date:  2019-09-19       Impact factor: 4.868

2.  Modified Terminal Restriction Fragment Analysis for Quantifying Telomere Length Using In-gel Hybridization.

Authors:  Frank J Jenkins; Charles M Kerr; Elise Fouquerel; Dana H Bovbjerg; Patricia L Opresko
Journal:  J Vis Exp       Date:  2017-07-10       Impact factor: 1.355

3.  GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells.

Authors:  Laura Pintado-Berninches; Beatriz Fernandez-Varas; Carlos Benitez-Buelga; Cristina Manguan-Garcia; Almudena Serrano-Benitez; Laura Iarriccio; Jaime Carrillo; Guillermo Guenechea; Susana P Egusquiaguirre; Jose-Luis Pedraz; Rosa M Hernández; Manoli Igartua; Elena G Arias-Salgado; Felipe Cortés-Ledesma; Leandro Sastre; Rosario Perona
Journal:  Cell Death Differ       Date:  2019-01-22       Impact factor: 15.828

Review 4.  Noncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging.

Authors:  Martina Rossi; Myriam Gorospe
Journal:  Trends Mol Med       Date:  2020-02-28       Impact factor: 11.951

Review 5.  Ring chromosomes: from formation to clinical potential.

Authors:  Inna E Pristyazhnyuk; Aleksei G Menzorov
Journal:  Protoplasma       Date:  2017-09-12       Impact factor: 3.356

Review 6.  Comparison of telomere length measurement methods.

Authors:  Tsung-Po Lai; Woodring E Wright; Jerry W Shay
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-05       Impact factor: 6.237

Review 7.  Influence of anaerobic and aerobic exercise on age-related pathways in skeletal muscle.

Authors:  Ignacio Navas-Enamorado; Michel Bernier; Gloria Brea-Calvo; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2017-05-06       Impact factor: 10.895

8.  Study of Telomere Length in Preimplanted Cultured Chondrocytes.

Authors:  Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Marta Guillén-Vicente; Tomás Fernando Fernández-Jaén; Rosa Caballero; Mercedes Casqueiro; Pilar Najarro; Steve Abelow; Pedro Guillén-García
Journal:  Cartilage       Date:  2018-01-11       Impact factor: 4.634

Review 9.  Convergence of The Nobel Fields of Telomere Biology and DNA Repair.

Authors:  Elise Fouquerel; Patricia L Opresko
Journal:  Photochem Photobiol       Date:  2017-01-30       Impact factor: 3.421

10.  Editorial.

Authors:  Robert M Brosh
Journal:  Ageing Res Rev       Date:  2016-09-29       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.